CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
Clarksville, Indiana, United States and 84 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
New Albany, Indiana, United States and 27 other locations
Metal allergen patch test study.
Phase 3
Louisville, Kentucky, United States
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
New Albany, Indiana, United States and 71 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
Clarksville, Indiana, United States and 60 other locations
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Phase 2
New Albany, Indiana, United States and 102 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Louisville, Kentucky, United States and 110 other locations
This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...
Phase 2
Louisville, Kentucky, United States and 118 other locations
Period 2, participants that completed Period 1 will either remain on their assigned dose or be reassigned to a different dose based on their Eczema...
Phase 3
Louisville, Kentucky, United States and 130 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Louisville, Kentucky, United States and 342 other locations
Clinical trials
Research sites
Resources
Legal